Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $128.00.
A number of brokerages have recently issued reports on ADUS. Bank of America reissued a “neutral” rating and issued a $125.00 price objective (down from $140.00) on shares of Addus HomeCare in a research note on Monday, September 14th. Raymond James Financial set a $125.00 target price on shares of Addus HomeCare in a report on Monday, September 14th. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Citigroup downgraded Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. Finally, Barclays upped their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th.
Read Our Latest Report on Addus HomeCare
Institutional Investors Weigh In On Addus HomeCare
Addus HomeCare Trading Down 1.0%
Shares of NASDAQ:ADUS opened at $114.24 on Friday. The stock has a 50 day moving average of $116.91 and a 200 day moving average of $103.83. The company has a market cap of $2.13 billion, a PE ratio of 20.04, a price-to-earnings-growth ratio of 1.65 and a beta of 0.86. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare has a 12-month low of $87.95 and a 12-month high of $124.43.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million. During the same quarter last year, the business earned $1.49 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. As a group, equities research analysts expect that Addus HomeCare will post 6.3 EPS for the current year.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides home-based care services to older adults, people with disabilities and individuals with chronic or complex medical needs. The company operates through three primary service lines: personal care, hospice and home health.
Its personal care services include assistance with daily living activities, such as bathing, dressing, meal preparation and household tasks. Addus also provides hospice care for individuals with terminal illnesses, as well as home health services that may include skilled nursing, therapy and other clinical support.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
